Abstract
Background: Sevoflurane (Sev) is a type of volatile anesthetic commonly used in clinic practices and can initiate long-term neurotoxicity, while dexmedetomidine (Dex) possesses a neuroprotective function in multiple neurological disorders.
Objective: This work expounded on the function of Dex pretreatment in Sev-initiated neurotoxicity.
Methods: At first, human neuroblastoma cells (SK-N-SH cells) were treated with different concentrations of Sev or Dex, followed by the cell counting kit (CCK)-8 assay to decide the appropriate concentrations of Sev or Dex. Cell viability, lactate dehydrogenase (LDH) productions, and apoptotic rate of SK-N-SH cells were examined by the CCK-8 assay, LDH cytotoxicity kit, and flow cytometry assay in sequence. Further, reactive oxygen species (ROS) levels and proinflammatory cytokine contents were examined by the ROS assay kit and the enzyme-linked immunosorbent assay kits. The expression patterns of microRNA (miR)-204-5p and SRY-box transcription factor 4 (SOX4) in SK-N-SH cells were measured by real-time quantitative polymerase chain reaction or Western blotting. The binding relationship between miR-204-5p and SOX4 was confirmed by the dual-luciferase assay. After transfection of miR-204-5p mimics or SOX4 siRNA, the role of the miR-204-5p/SOX4 axis in Sev-initiated neurotoxicity was detected.
Results: Sev treatment reduced SK-N-SH cell viability in a concentration-dependent manner, and Dex pretreatment diminished Sev-initiated neurotoxicity. Mechanically, Dex pretreatment limited Sevinduced upregulation of miR-204-5p and further increased SOX4 expression levels. miR-204-5p upregulation or SOX4 knockdown averted the neuroprotection function of Dex pretreatment in Sevinitiated neurotoxicity.
Conclusion: Dex pretreatment decreased miR-204-5p expression levels and upregulated SOX4 expression levels, palliating Sev-initiated neurotoxicity.
Graphical Abstract
[http://dx.doi.org/10.1002/14651858.CD007084.pub2] [PMID: 25212274]
[http://dx.doi.org/10.1016/j.jclinane.2021.110488] [PMID: 34481361]
[http://dx.doi.org/10.3389/fnagi.2021.702231] [PMID: 34305576]
[http://dx.doi.org/10.1016/j.clinthera.2021.01.024] [PMID: 33674065]
[http://dx.doi.org/10.1007/s10565-021-09677-y] [PMID: 34766256]
[http://dx.doi.org/10.23736/S0375-9393.19.13820-5] [PMID: 31630510]
[http://dx.doi.org/10.11124/jbisrir-2015-2257] [PMID: 26767820]
[http://dx.doi.org/10.3349/ymj.2016.57.4.998] [PMID: 27189297]
[http://dx.doi.org/10.1111/ejn.15474] [PMID: 34561931]
[http://dx.doi.org/10.1016/j.brainresbull.2020.08.003] [PMID: 32798600]
[http://dx.doi.org/10.1007/s11033-020-05868-8] [PMID: 33044702]
[http://dx.doi.org/10.1002/jcp.27486] [PMID: 30471116]
[http://dx.doi.org/10.1016/j.jchemneu.2022.102072] [PMID: 35063638]
[http://dx.doi.org/10.1002/iub.2344] [PMID: 32687247]
[http://dx.doi.org/10.14670/HH-18-266] [PMID: 33006132]
[http://dx.doi.org/10.1002/jbt.22919] [PMID: 34590382]
[http://dx.doi.org/10.1016/j.semcancer.2019.08.027] [PMID: 31445218]
[http://dx.doi.org/10.1007/s00441-017-2708-7] [PMID: 29079881]
[http://dx.doi.org/10.1002/jcp.29011] [PMID: 31264218]
[http://dx.doi.org/10.1093/nar/gkt1248] [PMID: 24297251]
[http://dx.doi.org/10.1093/nar/gkz896] [PMID: 31647101]
[http://dx.doi.org/10.1016/j.cell.2006.07.031] [PMID: 16990141]
[http://dx.doi.org/10.1093/nar/gkz757] [PMID: 31504780]
[http://dx.doi.org/10.7554/eLife.05005] [PMID: 26267216]
[http://dx.doi.org/10.1006/meth.2001.1262] [PMID: 11846609]
[http://dx.doi.org/10.1007/s00540-020-02812-9] [PMID: 32601887]
[http://dx.doi.org/10.3389/fnagi.2021.717745] [PMID: 34421578]
[http://dx.doi.org/10.1016/j.brainresbull.2020.10.011] [PMID: 33080307]
[http://dx.doi.org/10.3390/brainsci11070846] [PMID: 34202110]
[http://dx.doi.org/10.1055/s-0041-1730349] [PMID: 34044458]
[http://dx.doi.org/10.1248/bpb.b20-00482] [PMID: 34193687]
[http://dx.doi.org/10.5607/en20032] [PMID: 33154198]
[http://dx.doi.org/10.1007/s00540-018-2545-1] [PMID: 30128750]
[http://dx.doi.org/10.1186/s12871-019-0808-5] [PMID: 31351473]
[http://dx.doi.org/10.2147/DDDT.S180343] [PMID: 30464393]
[http://dx.doi.org/10.1016/j.neuro.2012.02.013] [PMID: 22394481]
[http://dx.doi.org/10.1007/s13258-019-00851-5] [PMID: 31350734]
[http://dx.doi.org/10.1002/brb3.2556] [PMID: 35726359]
[http://dx.doi.org/10.1089/dna.2016.3623] [PMID: 28436683]
[http://dx.doi.org/10.1186/s40360-022-00555-9] [PMID: 35337381]
[http://dx.doi.org/10.1016/j.reth.2020.03.001] [PMID: 32467829]
[http://dx.doi.org/10.3389/fncel.2019.00399] [PMID: 31572127]
[http://dx.doi.org/10.1177/09603271211009970] [PMID: 33878909]
[http://dx.doi.org/10.3389/fnmol.2021.654031] [PMID: 33867936]
[http://dx.doi.org/10.1523/JNEUROSCI.4679-11.2012] [PMID: 22378879]
[http://dx.doi.org/10.1691/ph.2017.7616] [PMID: 29442040]
[http://dx.doi.org/10.1590/1414-431x20176803] [PMID: 29490000]
[http://dx.doi.org/10.3389/fvets.2021.654694] [PMID: 34235197]
[http://dx.doi.org/10.1111/nep.13833] [PMID: 33207024]